Primary Hyperparathyroidism in a Poor Surgical Candidate: Cinacalcet or Push for Surgery
A single patient whose parathyroid disease has a clear surgical cure that her heart may not tolerate well. The disagreement is whether medical therapy is a genuine alternative or a compromise being reached for too quickly.
Beatrice N., a 77-year-old woman, has managed a moderate heart failure diagnosis for the better part of a decade, carefully enough that she still drives herself to her weekly bridge game and has not been hospitalized for a cardiac decompensation in over three years. Persistent fatigue and constipation that her primary care physician initially attributed to the heart failure traced instead, on a routine metabolic panel, to an elevated calcium and an inappropriately high PTH. A sestamibi scan localized a single right inferior adenoma.
By every criterion apart from her cardiac history she is a straightforward parathyroidectomy referral, and her own numbers are what establish that rather than a general impression. Her corrected calcium of 11.4 is more than a milligram above the upper limit of normal, which is itself a standard criterion for recommending surgery in primary hyperparathyroidism; her PTH of 138 is inappropriate against it; her femoral neck T-score of −2.4 is the skeletal cost accumulating while the adenoma runs. That matters for how the medical alternative is described, because cinacalcet's FDA indication in primary hyperparathyroidism has two limbs, not one: patients for whom parathyroidectomy would be indicated on the basis of serum calcium levels, and who are unable to undergo it. She clears the first limb outright. Everything therefore turns on the second. And the second has not actually been assessed. She underwent a cataract procedure under monitored anesthesia care eighteen months ago without cardiac complication, which her endocrinologist has cited as reassurance — but a parathyroidectomy is general anesthesia, neck positioning and a longer duration, and nobody has confirmed how her heart tolerates that combination rather than assuming the cataract case predicts it. On the numbers she is already a surgical candidate, and the only thing standing between her and the operating room is an assessment nobody has ordered for the operation actually being contemplated.
What her heart has actually been tested against
Given her cardiac history, I'd start cinacalcet rather than push toward surgery. It's FDA-approved for hypercalcemia in primary hyperparathyroidism, and the indication is worth quoting precisely because it has two halves: patients for whom parathyroidectomy would be indicated on the basis of serum calcium levels, but who are unable to undergo it. Her corrected calcium of 11.4 clears the first half — more than a milligram above the upper limit of normal is a standard surgical criterion — so she turns on the second.
I'd want to separate "surgery isn't appropriate" from "surgery hasn't been formally assessed." She tolerated a comparable-risk procedure eighteen months ago without complication, and parathyroidectomy is curative in a way cinacalcet, which manages her calcium but doesn't touch her bone density or the adenoma itself, is not.
I'm not saying her cardiac history is irrelevant — I'm saying "comparable-risk" is doing a lot of work in that sentence, and I don't think it's actually been confirmed for this specific procedure.
That's the real gap. Her cataract procedure was monitored anesthesia care — a parathyroidectomy is general anesthesia, neck positioning, longer duration. Those aren't interchangeable from a cardiac-risk standpoint, and nobody has run a formal risk assessment for the actual procedure being considered.
Her cardiac history is real but not automatically prohibitive — before deciding between a curative and a chronic-management option, I'd want that specific assessment done, rather than either of you deciding based on how a different procedure went.
Agreed: start cinacalcet now to control her calcium while cardiology completes a formal, procedure-specific risk assessment for parathyroidectomy, rather than assuming her cataract procedure's smooth course predicts how she'd tolerate the actual surgery being considered.
Not fully settled: what the group will do if the assessment comes back genuinely ambiguous rather than clearly favorable or unfavorable — no explicit fallback plan was set for that middle scenario, left for the cardiologist and endocrinologist to work through once real numbers exist.